In the international arena, KORI operates in Latin America, Africa and Asia. We also offer contact manufacturing services to our international strategic alliances. The Company remains focused on ascending the value chain in the marketing of pharmaceutical substances and is determined to bring in increased revenues from the sales of various dosage forms.
Our diverse product basket encompasses a wide therapeutic mix covering majority of the chronic and acute segments. Healthcare trends project that the chronic treatment segments will outpace the acute treatment segments, primarily driven by a growing aging population and dominance of lifestyle diseases. Our focus remains on strengthening Cardiovasculars, Respiratory, Dermatology, Nutritionals and Urology segments, which clearly indicates our path of increasing our presence in the fast-growing chronic and lifestyle disease segments.
